Prevalences of diabetic retinopathy and nephropathy are lower in Korean type 2 diabetic patients with non-alcoholic fatty liver disease

被引:61
作者
Kim, Bo-Yeon [1 ]
Jung, Chan-Hee [1 ]
Mok, Ji-Oh [1 ]
Kang, Sung Koo [1 ]
Kim, Chul-Hee [1 ]
机构
[1] Soonchunhyang Univ, Bucheon Hosp, Div Endocrinol & Metab, Dept Internal Med, Puchon, South Korea
来源
JOURNAL OF DIABETES INVESTIGATION | 2014年 / 5卷 / 02期
关键词
Diabetes mellitus type 2; Diabetic angiopathies; Non-alcoholic fatty liver disease; CORONARY-HEART-DISEASE; C-PEPTIDE; CARDIOVASCULAR-DISEASE; LIPID-PEROXIDATION; RISK-FACTORS; EVENTS;
D O I
10.1111/jdi.12139
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/IntroductionThe associations between non-alcoholic fatty liver disease (NAFLD) and chronic vascular complications of type 2 diabetes remain uncertain. We assessed the relationships between NAFLD and chronic vascular complications in patients with type 2 diabetes. Materials and MethodsPatients with type 2 diabetes (n=929) attending a diabetes clinic of a university hospital were studied retrospectively. Patients who had any clinical evidence of cirrhosis or other causes of chronic liver disease were excluded. Prevalences of chronic microvascular and macrovascular complications were assessed. NAFLD was ascertained by ultrasonography. ResultsThe prevalence of NAFLD in patients with type 2 diabetes was 63.3%. The prevalences of diabetic retinopathy and nephropathy were significantly lower in patients with NAFLD than those without NAFLD (33.0 vs 70.2%, P<0.001; 29.3 vs 37.1%, P=0.007, respectively), whereas no difference was found in the prevalence of diabetic neuropathy. The prevalence of diabetic macrovascular complications was lower in type 2 diabetic patients with NAFLD than those without NAFLD (9.2 vs 14.7%, P=0.008). After adjustment for confounding factors, such as age, sex, glycated hemoglobin, fasting serum C-peptide, diabetic duration, body mass index and hypertension, NAFLD remained significantly associated with a lower odds ratio (OR) of diabetic retinopathy (OR 0.440, 95% confidence interval 0.255-0.757, P=0.003) and nephropathy, (OR 0.541, 95% confidence interval 0.358-0.817, P=0.003). In contrast, NAFLD was not significantly associated with macrovascular complications after adjustment for confounding factors. ConclusionsThese results suggest that NAFLD is inversely associated with prevalences of diabetic retinopathy and nephropathy in Korean patients with type 2 diabetes.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 50 条
  • [31] Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes
    Targher, Giovanni
    Bertolini, Lorenzo
    Padovani, Roberto
    Rodella, Stefano
    Zoppini, Giacomo
    Pichiri, Isabella
    Sorgato, Claudia
    Zenari, Luciano
    Bonora, Enzo
    JOURNAL OF HEPATOLOGY, 2010, 53 (04) : 713 - 718
  • [32] Recent News on Statins for the Treatment of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis
    Athyros, Vasilios G.
    Katsiki, Niki
    Doumas, Michael
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (02) : 104 - 106
  • [33] Non-alcoholic fatty liver disease and type 2 diabetes: An update
    Lee, Chi-H
    Lui, David T. W.
    Lam, Karen S. L.
    JOURNAL OF DIABETES INVESTIGATION, 2022, 13 (06) : 930 - 940
  • [34] Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Pittaras, Andreas
    Faselis, Charles
    Narayan, Puneet
    Kokkinos, Peter
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (03) : 239 - 245
  • [35] Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Lee, Byung-Wan
    Lee, Yong-Ho
    Park, Cheol-Young
    Rhee, Eun-Jung
    Lee, Won-Young
    Kim, Nan-Hee
    Choi, Kyung Mook
    Park, Keun-Gyu
    Choi, Yeon-Kyung
    Cha, Bong-Soo
    Lee, Dae Ho
    DIABETES & METABOLISM JOURNAL, 2020, 44 (03) : 382 - 401
  • [36] Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications
    Yan, Li-hui
    Mu, Biao
    Guan, Yue
    Liu, Xinyu
    Zhao, Nan
    Pan, Da
    Wang, Shao-zhen
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (06): : 889 - 894
  • [37] Relationship between cerebral arterial pulsatility and carotid intima media thickness in diabetic and non-diabetic patients with non-alcoholic fatty liver disease
    Karakurt, F.
    Carlioglu, A.
    Koktener, A.
    Ozbek, M.
    Kaya, A.
    Uyar, M. E.
    Kasapoglu, B.
    Ilhan, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (01): : 63 - 68
  • [38] Exenatide improves type 2 diabetes concomitant with non-alcoholic fatty liver disease
    Fan, Hui
    Pan, QingRong
    Xu, Yuan
    Yang, XinChun
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2013, 57 (09) : 702 - 708
  • [39] High levels of serum dihomo-γ-linolenic acid are associated with non-alcoholic fatty liver disease in type 2 diabetic patients
    Mochizuki, Kohei
    Higa, Mariko
    Ikehara, Kayoko
    Ichijo, Takamasa
    Hirose, Takahisa
    DIABETOLOGY INTERNATIONAL, 2025, 16 (01) : 107 - 114
  • [40] Polymorphism of human leptin receptor gene is associated with type 2 diabetic patients complicated with non-alcoholic fatty liver disease in China
    Lu, Hongyun
    Sun, Jiazhong
    Sun, Liao
    Shu, Xiaochun
    Xu, Yancheng
    Xie, Danhong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (02) : 228 - 232